Page last updated: 2024-09-02

carboxyamido-triazole and Inflammatory Bowel Diseases

carboxyamido-triazole has been researched along with Inflammatory Bowel Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, C; Chen, W; Du, X; Guo, L; Ju, R; Li, J; Wang, Y; Ye, C; Zhang, D; Zhu, L1
Guo, L; Hao, X; Ju, R; Li, J; Luo, L; Wang, C; Wu, D; Ye, C; Yu, X; Zhang, D; Zheng, R; Zhu, L1

Other Studies

2 other study(ies) available for carboxyamido-triazole and Inflammatory Bowel Diseases

ArticleYear
Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation.
    International immunopharmacology, 2017, Volume: 45

    Topics: Animals; Cells, Cultured; Colitis; Colon; Cytokines; Female; Gene Expression Regulation; Humans; Inflammasomes; Inflammatory Bowel Diseases; Intestines; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Signal Transduction; Triazoles; Trinitrobenzenesulfonic Acid

2017
Carboxyamidotriazole ameliorates experimental colitis by inhibition of cytokine production, nuclear factor-κB activation, and colonic fibrosis.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 342, Issue:2

    Topics: Animals; Colitis; Colon; Dextran Sulfate; Fibrosis; Inflammation; Inflammatory Bowel Diseases; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mucous Membrane; NF-kappa B; Phosphorylation; Proteolysis; Triazoles; Tumor Necrosis Factor-alpha

2012